NYSE - Nasdaq Real Time Price USD

Thermo Fisher Scientific Inc. (TMO)

Compare
513.08 -19.94 (-3.74%)
At close: November 15 at 4:00 PM EST
516.66 +3.58 (+0.70%)
After hours: November 15 at 7:41 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
42,370,000.00
42,857,000.00
44,915,000.00
39,211,000.00
32,218,000.00
Cost of Revenue
25,097,000.00
25,757,000.00
25,944,000.00
19,573,000.00
16,214,000.00
Gross Profit
17,273,000.00
17,100,000.00
18,971,000.00
19,638,000.00
16,004,000.00
Operating Expense
9,867,000.00
9,782,000.00
10,464,000.00
9,413,000.00
8,111,000.00
Operating Income
7,406,000.00
7,318,000.00
8,507,000.00
10,225,000.00
7,893,000.00
Net Non Operating Interest Income Expense
-303,000.00
-496,000.00
-454,000.00
-493,000.00
-488,000.00
Other Income Expense
-266,000.00
-524,000.00
-218,000.00
-891,000.00
-175,000.00
Pretax Income
6,836,000.00
6,298,000.00
7,835,000.00
8,841,000.00
7,230,000.00
Tax Provision
640,000.00
284,000.00
703,000.00
1,109,000.00
850,000.00
Earnings from Equity Interest Net of Tax
-76,000.00
-59,000.00
-172,000.00
-4,000.00
-3,000.00
Net Income Common Stockholders
6,135,000.00
5,995,000.00
6,950,000.00
7,725,000.00
6,375,000.00
Diluted NI Available to Com Stockholders
6,135,000.00
5,995,000.00
6,950,000.00
7,725,000.00
6,375,000.00
Basic EPS
16.00
15.52
17.75
19.62
16.09
Diluted EPS
15.95
15.45
17.63
19.46
15.96
Basic Average Shares
383,000.00
386,000.00
392,000.00
394,000.00
396,000.00
Diluted Average Shares
384,250.00
388,000.00
394,000.00
397,000.00
399,000.00
Total Operating Income as Reported
7,175,000.00
6,859,000.00
8,393,000.00
10,028,000.00
7,794,000.00
Total Expenses
34,964,000.00
35,539,000.00
36,408,000.00
28,986,000.00
24,325,000.00
Net Income from Continuing & Discontinued Operation
6,135,000.00
5,995,000.00
6,950,000.00
7,725,000.00
6,375,000.00
Normalized Income
6,344,373.32
6,433,345.00
7,053,740.00
7,897,375.00
6,462,318.00
Interest Income
1,160,000.00
879,000.00
272,000.00
43,000.00
65,000.00
Interest Expense
1,463,000.00
1,375,000.00
726,000.00
536,000.00
553,000.00
Net Interest Income
-303,000.00
-496,000.00
-454,000.00
-493,000.00
-488,000.00
EBIT
8,299,000.00
7,673,000.00
8,561,000.00
9,377,000.00
7,783,000.00
EBITDA
11,504,000.00
11,079,000.00
11,942,000.00
11,969,000.00
10,108,000.00
Reconciled Cost of Revenue
25,097,000.00
25,757,000.00
25,944,000.00
19,573,000.00
16,214,000.00
Reconciled Depreciation
3,205,000.00
3,406,000.00
3,381,000.00
2,592,000.00
2,325,000.00
Net Income from Continuing Operation Net Minority Interest
6,135,000.00
5,995,000.00
6,950,000.00
7,725,000.00
6,375,000.00
Total Unusual Items Excluding Goodwill
-231,000.00
-459,000.00
-114,000.00
-197,000.00
-99,000.00
Total Unusual Items
-231,000.00
-459,000.00
-114,000.00
-197,000.00
-99,000.00
Normalized EBITDA
11,735,000.00
11,538,000.00
12,056,000.00
12,166,000.00
10,207,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-21,626.68
-20,655.00
-10,260.00
-24,625.00
-11,682.00
12/31/2020 - 3/17/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers